| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 6.851 | 17.775 | 49.106 | 72.660 | 100.480 |
| Total Income - EUR | - | - | - | - | - | 6.851 | 17.775 | 49.106 | 72.660 | 100.481 |
| Total Expenses - EUR | - | - | - | - | - | 8.637 | 21.158 | 42.962 | 58.629 | 72.104 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -1.786 | -3.383 | 6.144 | 14.032 | 28.377 |
| Net Profit/Loss - EUR | - | - | - | - | - | -1.854 | -3.574 | 5.663 | 13.414 | 25.423 |
| Employees | - | - | - | - | - | 1 | 2 | 5 | 4 | 4 |
Check the financial reports for the company - N.g.a. Ideal Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 1.961 | 1.537 | 2.707 | 29.916 | 38.383 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 192 | 191 |
| Receivables | - | - | - | - | - | 785 | 1.269 | 1.333 | 15.368 | 17.713 |
| Cash | - | - | - | - | - | 1.176 | 268 | 1.373 | 14.356 | 20.479 |
| Shareholders Funds | - | - | - | - | - | -1.813 | -5.347 | 299 | 13.454 | 25.463 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 3.774 | 6.883 | 2.408 | 16.462 | 12.920 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - N.g.a. Ideal Med S.r.l.